{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-119894","form_type":"8-K","ticker":"APUS","cik":"0001894525","company_name":"Apimeds Pharmaceuticals US, Inc.","filed_at":"2025-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.007113+00:00","generated_at":"2026-05-16T13:40:57.946610+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Two directors resign from Apimeds Pharmaceuticals board effective December 5, 2025","bullets":["Dr. Vin Menon and Amir A. Dossal resigned from the Board of Directors on December 5, 2025.","Resignations were not due to any disagreement with the company's operations, policies, or practices.","Dr. Vin Menon remains CEO of the company; no replacements for the vacant board seats announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-119894","json":"https://secwatch.observer/filing/0001213900-25-119894.json","markdown":"https://secwatch.observer/filing/0001213900-25-119894.md","text":"https://secwatch.observer/filing/0001213900-25-119894.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119894/0001213900-25-119894-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119894/ea0268648-8k_apimeds.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:40:57.946610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}